Top Markets
#1 EXOD EXOD +22.78%
#2 Status Status +8.56%
#3 Tornado Cash Tornado Cash +4.89%
#4 Ontology Gas Ontology Gas +4.17%
#5 The Black Bull The Black Bull +2.72%
#6 HOME HOME +2.58%
#7 Anvil Anvil +2.51%
#8 Velvet Velvet +2.28%
#9 Fractal Bitcoin Fractal Bitcoin +2.26%
#10 The Grays Currency The Grays Currency +2.17%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Alpha Cognition Inc Alpha Cognition Inc

Alpha Cognition Inc

ACOG
Rangering i aksjer #19830
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Aksjekurs
$9.61
Markedsverdi
$149.33M
Endring (1 dag)
-1.39%
Endring (1 år)
24.38%
Land
US
Handel Alpha Cognition Inc (ACOG)

Kategori

Healthcare
Inntekter for Alpha Cognition Inc (ACOG)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Alpha Cognition Inc er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Alpha Cognition Inc fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH